Virologic Suppression Maintained During Treatment With B/F/TAF In African American Adults With HIV, Findings Show
October 14, 2021
Infectious Disease Advisor (10/13, van Paridon) reports, “Among African American patients with HIV infection, virologic suppression was maintained during treatment with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF), regardless of pre-existing...